32854315|t|Proteomic Profiling of Extracellular Vesicles Derived from Cerebrospinal Fluid of Alzheimer's Disease Patients: A Pilot Study.
32854315|a|Pathological hallmarks of Alzheimer's disease (AD) are deposits of amyloid beta (Abeta) and hyper-phosphorylated tau aggregates in brain plaques. Recent studies have highlighted the importance of Abeta and tau-containing extracellular vesicles (EVs) in AD. We therefore examined EVs separated from cerebrospinal fluid (CSF) of AD, mild cognitive impairment (MCI), and control (CTRL) patient samples to profile the protein composition of CSF EV. EV fractions were separated from AD (n = 13), MCI (n = 10), and CTRL (n = 10) CSF samples using MagCapture Exosome Isolation kit. The CSF-derived EV proteins were identified and quantified by label-free and tandem mass tag (TMT)-labeled mass spectrometry. Label-free proteomics analysis identified 2546 proteins that were significantly enriched for extracellular exosome ontology by Gene Ontology analysis. Canonical Pathway Analysis revealed glia-related signaling. Quantitative proteomics analysis, moreover, showed that EVs expressed 1284 unique proteins in AD, MCI and CTRL groups. Statistical analysis identified three proteins-HSPA1A, NPEPPS, and PTGFRN-involved in AD progression. In addition, the PTGFRN showed a moderate correlation with amyloid plaque (rho = 0.404, p = 0.027) and tangle scores (rho = 0.500, p = 0.005) in AD, MCI and CTRL. Based on the CSF EV proteomics, these data indicate that three proteins, HSPA1A, NPEPPS and PTGFRN, may be used to monitor the progression of MCI to AD.
32854315	82	101	Alzheimer's Disease	Disease	MESH:D000544
32854315	102	110	Patients	Species	9606
32854315	153	172	Alzheimer's disease	Disease	MESH:D000544
32854315	174	176	AD	Disease	MESH:D000544
32854315	194	206	amyloid beta	Gene	351
32854315	208	213	Abeta	Gene	351
32854315	240	243	tau	Gene	4137
32854315	323	328	Abeta	Gene	351
32854315	333	336	tau	Gene	4137
32854315	380	382	AD	Disease	MESH:D000544
32854315	454	456	AD	Disease	MESH:D000544
32854315	458	483	mild cognitive impairment	Disease	MESH:D060825
32854315	485	488	MCI	Disease	MESH:D060825
32854315	510	517	patient	Species	9606
32854315	568	570	EV	Disease	MESH:D004819
32854315	572	574	EV	Disease	MESH:D004819
32854315	605	607	AD	Disease	MESH:D000544
32854315	618	621	MCI	Disease	MESH:D060825
32854315	718	720	EV	Disease	MESH:D004819
32854315	1133	1135	AD	Disease	MESH:D000544
32854315	1137	1140	MCI	Disease	MESH:D060825
32854315	1205	1211	HSPA1A	Gene	3303
32854315	1213	1219	NPEPPS	Gene	9520
32854315	1225	1231	PTGFRN	Gene	5738
32854315	1244	1246	AD	Disease	MESH:D000544
32854315	1277	1283	PTGFRN	Gene	5738
32854315	1319	1326	amyloid	Disease	MESH:C000718787
32854315	1405	1407	AD	Disease	MESH:D000544
32854315	1409	1412	MCI	Disease	MESH:D060825
32854315	1440	1442	EV	Disease	MESH:D004819
32854315	1496	1502	HSPA1A	Gene	3303
32854315	1504	1510	NPEPPS	Gene	9520
32854315	1515	1521	PTGFRN	Gene	5738
32854315	1565	1568	MCI	Disease	MESH:D060825
32854315	1572	1574	AD	Disease	MESH:D000544
32854315	Association	MESH:D000544	4137
32854315	Association	MESH:D000544	9520
32854315	Association	MESH:C000718787	5738
32854315	Association	MESH:D000544	351
32854315	Association	MESH:D000544	5738
32854315	Association	MESH:D060825	5738
32854315	Association	MESH:D000544	3303

